A series of 6BrCaQ-C-TPP conjugates 3a-f and 5 was designed and synthesized as a novel class of TRAP1 inhibitors. Compound 3a displayed an excellent anti-proliferative activity with mean GI values at a nanomolar level in a diverse set of human cancer cells (GI = 0.008-0.
View Article and Find Full Text PDF